← Leaderboards
John Joseph Siekierka
Rbhs-New Jersey Medical School
$705,905
Attributed
$2,117,715
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $721.2K · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$2,117,715 · 1
By mechanism
R01$2,117,715 · 1
Top collaborators
- Purnima Bhanot3 shared
- David Rotella3 shared
Most similar at Rbhs-New Jersey Medical School
Same institution · by research overlap
- David Rotella$1,892,526
Others in their field
Other Emerging Leaders on “Ensure”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$142,551,806
Research focus
EnsureEnzymesAnimalsAllelesAppearanceEnzymatic BiochemistryAsexualBackBaseAntimalarialsBiologyBloodCellsAnalogChemopreventionChemoprotectionChemoprotective AgentCyclic Gmp-Dependent Protein KinasesCytotoxicity TestDesignBinding ProteinsDrug TargetingEfficacy TestingErythrocytes
Grant awards (3)
Development of inhibitors of P. falciparum cGMP dependent protein kinase (PfPKG) for malaria chemoprevention$694,721
R01 · FY2019 · AI
Development of inhibitors of P. falciparum cGMP dependent protein kinase (PfPKG) for malaria chemoprevention$701,820
R01 · FY2018 · AI
Development of inhibitors of P. falciparum cGMP dependent protein kinase (PfPKG) for malaria chemoprevention$721,174
R01 · FY2017 · AI